Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19
Clinical trial NCT04542213 · COMPLETED
Trial details
- NCT number
- NCT04542213
- Sponsor
- Hospital Regional de Alta Especialidad del Bajio
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2021-02-28
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.